NovaBridge Biosciences Cash Flow Statement (2017-2025) | NBP

Cash Flow Statement Dec2017 Dec2018 Sep2019 Dec2019 Jun2020 Sep2020 Dec2020 Jun2021 Dec2021 Jun2022 Dec2022 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating Activities
Net Income (Quarter)
-0.04B-0.05B-0.08B0.16B-0.03B-0.01B0.03B0.03B-0.03B-0.00B-0.01B-0.01B-0.07B
Depreciation and Depletion (Quarter)
0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Share-based Compensation (Quarter)
-0.05B0.02B0.02B0.00B0.00B0.00B0.00B
Cash from Discontinued Operations (Quarter)
-0.03B0.03B0.03B0.06B
Gains from Sales and Divestitures (Quarter)
0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Gains from Investment Securities (Quarter)
0.01B0.00B0.00B-0.00B0.00B0.00B0.00B0.03B
Non-cash Items (Quarter)
0.06B0.21B0.00B0.00B0.02B
Cash from Operations (Quarter)
0.01B-0.01B0.00B-0.01B
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.00B-0.00B
Amortization of Deferred Charges (Quarter)
0.00B0.00B0.00B0.00B
Depreciation & Amortization (CF) (Quarter)
0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Change in Working Capital
Change in Accured Expenses (Quarter)
0.00B0.03B0.05B0.03B0.08B92.80B0.08B99.35B0.08B49.69B0.01B0.01B-0.00B0.01B0.01B0.02B0.01B
Other Working Capital Changes (Quarter)
-0.00B-0.00B-0.00B-0.00B
Investing Activities
Capital Expenditures (Quarter)
0.00B-0.00B0.00B-0.00B-0.00B
Change in Acquisitions & Divestments (Quarter)
0.03B0.02B0.34B
Cash from Investing Activities (Quarter)
0.01B-0.04B0.01B0.10B
Financing Activities
Other financing activities (Quarter)
-0.00B
Cash from Financing Activities (Quarter)
0.02B0.28B0.13B-0.00B0.06B
Additional items
Exchange Rate Effect (Quarter)
-0.01B-0.00B-0.02B0.00B-0.00B0.00B0.00B
Change in Cash (Quarter)
-0.01B0.20B0.27B-0.07B-0.01B0.06B-0.02B
Free Cash Flow (Quarter)
-0.00B0.00B-0.00B0.01B-0.01B0.00B-0.01B
Net Cash Flow (Quarter)
0.03B0.24B0.14B0.00B-0.01B0.00B0.15B